The year of living large: A fledgling Relay Therapeutics reaps a whopping $400M venture round, with SoftBank pointing the way to a windfall
Relay Therapeutics is wrapping a year packed with record financings with a stratospheric Series C round.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.